By BREAKING NEWS: Bharat Biotech to conduct Covaxin trial on age group between 2 to 18
The Drug Controller General of India on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children belonging to the age group of 2 to 18 years. Bharat Biotech will conduct the trials on 525 healthy volunteers, the Hyderabad-based firm said.
The decision comes after the subject expert committee recommended permission in favor of Bharat Biotech. The permission has been granted after “careful examination”, the government said.
Latest News and updates, Follow and connect with us on Facebook, Twitter, and Linkedin
Get the latest updates directly on your mobile, save and send a message at +91-9899909957 on Whatsapp to start
